Cargando…
Management of autosomal-dominant polycystic kidney disease—state-of-the-art
Autosomal-dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause of end-stage renal disease in adults. Affected individuals and families face a significant medical and psychosocial burden due to both renal and extrarenal manifestations. Consequently, interventions that amelior...
Autores principales: | Müller, Roman-Ulrich, Benzing, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295602/ https://www.ncbi.nlm.nih.gov/pubmed/30581561 http://dx.doi.org/10.1093/ckj/sfy103 |
Ejemplares similares
-
Developments in the management of autosomal dominant polycystic
kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008) -
Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan
por: Müller, Roman-Ulrich, et al.
Publicado: (2018) -
Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
por: Karner, Larina A., et al.
Publicado: (2022) -
Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022) -
Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
por: Arjune, Sita, et al.
Publicado: (2023)